logo

EVIDENCE • EXPERIENCE • OUTCOMES

INTELLIGENCE BYMDReviewer
Home
About
Peptides
Contact
Back
Pre-approval drug. This compound is in active clinical trials and is not yet FDA-approved. Information here is for situational awareness only and should not be used to inform prescribing decisions.
  • No Preview Available

Brenipatide

PipelinePhase 3PeptideInvestigationalNot approved yet. Being tested in human clinical trials.
Sponsor:
Eli Lilly and Company
Active US trials:
9
Earliest primary completion:
Feb 1, 2027
👋

No perspectives yet — be the first!

100% anonymous · Verified U.S. prescribers only

(no name, NPI, or practice ever shown)

On this page

  • Synopsis

Trials

  • Clinical trials
  • About this drug

Physicians

  • Physician Buzz
Similar Products
medicine
Brexpiprazole
medicine
ABILIFY
medicine
CAPLYTA
medicine
L-Methylfolate Calcium
Synopsis
Generated with AlphaAI
Product:
Brenipatide
Category:
Indication:
Mechanism:
Safety:
Dosing:
Patient:
Reviews:
No reviews yet
see more
Disclaimer: The synopsis and product information provided on Alpha.MD are derived from openFDA data and are for informational purposes only. This information may not be comprehensive, accurate, or up-to-date. Clinicians should exercise their own professional judgment in interpreting and using this information, and consult the official prescribing information for the most accurate and current details.

Clinical trials (9)

NCTPhaseStatusSponsorPrimary Completion
NCT07420283Phase 2RECRUITINGEli Lilly and CompanyMar 1, 2028
NCT07219173Phase 2RECRUITINGEli Lilly and CompanyApr 1, 2028
Status: Investigational
Not yet ratedEvidence: Not yet ratedWe have not yet attached proof for an evidence level.
NCT07219173
Phase 2
RECRUITING
Eli Lilly and Company
Apr 1, 2028
NCT07410507Phase 2RECRUITINGEli Lilly and CompanyNov 1, 2027
NCT07775300Phase 3RECRUITINGEli Lilly and CompanyDec 1, 2028
NCT07223840Phase 2RECRUITINGEli Lilly and CompanyFeb 1, 2027
NCT07759245Phase 2RECRUITINGEli Lilly and CompanyMay 1, 2028
NCT07412756Phase 3RECRUITINGEli Lilly and CompanyFeb 1, 2028
NCT07286175Phase 2RECRUITINGEli Lilly and CompanyNov 1, 2027

About this drug

Status
Active in clinical trials
Last Refreshed
Nov 13, 2026

Physician Buzz

Pre-Approval Insights

Be the First to Share Your Perspective

Share your pre-launch perspective on Brenipatide and help peers make informed prescribing decisions.

Your 45-second perspective helps thousands of colleagues.

Help Peers Make Better Decisions

Your real-world insights guide colleagues

Anonymous to Pharmaceutical Companies

Your identity stays private — only specialty/region shown

See Peer Benchmarks

Compare your perspective to specialty peers

There isn't any reviews posted yet. You can be the first to review the product